Rising Government Support and Demand for Non-Invasive Cancer Treatments Fuel Growth in Global Intensity Modulated Radiotherapy (IMRT) Market

The global market for Intensity Modulated Radiotherapy (IMRT) was valued at USD 2.21 billion in 2022 and is projected to grow steadily at a compound annual growth rate (CAGR) of 5.4% over the coming years, according to a recent report by Emergen Research. This growth is largely driven by increasing government support for cancer management and a growing preference for non-invasive cancer treatments.

IMRT is a sophisticated technology that customizes radiation doses to precisely match the shape and size of tumors, minimizing exposure to surrounding healthy tissue. This approach helps reduce side effects and enhances treatment outcomes. As the demand for targeted, less invasive treatments rises, IMRT is becoming a preferred choice for many patients and healthcare providers alike. Early cancer detection efforts and the rising need for precision in treatment are further accelerating demand for IMRT.

Download Free Exclusive Sample PDF@ https://www.emergenresearch.com/request-sample/2391

One notable example is the partnership formed in early 2023 between Varian, a subsidiary of Siemens Healthineers, and Nova Scotia Health. This collaboration aims to upgrade Nova Scotia's oncology services, creating a digitally integrated system for better management and delivery of cancer treatments over the next five years.

Growth of Proton Therapy for Cancer Treatment

A significant trend in the IMRT market is the adoption of proton therapy, particularly for elderly cancer patients. In the United States, over 30 hospitals have invested in proton therapy facilities, given its effectiveness in delivering precise doses to tumors while sparing surrounding healthy tissue. Studies by the American Society of Clinical Oncology (ASCO) highlight that proton therapy can reduce radiation exposure to healthy tissue by up to 60%, making it an appealing choice for various cancer types.

Key Market Segments in IMRT

The report notes that the proton radiation segment is anticipated to hold the largest share of the IMRT market due to its effectiveness in targeting cancer cells while protecting healthy tissue. Proton therapy has applications beyond cancer treatment, including conditions such as brain and spinal cord tumors and even pancreatic cancer.

Additionally, the breast cancer segment within the IMRT market is expected to grow steadily as cases and fatalities linked to breast cancer remain high. The World Health Organization (WHO) reported 2.3 million new breast cancer cases globally in 2020, resulting in 685,000 deaths. IMRT helps to minimize remaining cancer cells in breast tissue and lymph nodes, lowering the risk of recurrence.

Cancer treatment centers are another growing segment, offering specialized services for ongoing patient monitoring and therapy. Many hospitals partner with these centers to deliver targeted anti-cancer treatments and other essential services.

North America Leads Market with Advanced Healthcare Infrastructure

In terms of regional revenue, North America accounted for the largest share of the IMRT market in 2022. The region benefits from advanced healthcare infrastructure and wider insurance coverage, allowing more patients access to these specialized treatments. Additionally, high levels of investment in cancer research and healthcare technology in the U.S. contribute to this growth. According to ASCO, more than 3.8 million women are currently living with breast cancer in the U.S., underscoring the importance of continuous innovation in cancer treatment.

Major Companies in IMRT Market

Leading companies driving advancements in the global IMRT market include Hitachi, Ltd., Varian Medical Systems, Accuray Incorporated, Elekta, IBA Proton Therapy, Mevion Medical Systems, Panacea Medical Technologies, Proton International, Koninklijke Philips N.V., and Mirion Technologies. Notably, in mid-2023, Grovecourt Capital Partners acquired Premier Radiology Services, a nationally recognized teleradiology provider, to enhance its footprint in the radiology sector.

Interested in knowing more relevant information? Click here: https://www.emergenresearch.com/industry-report/intensity-modulated-radiotherapy-market

The report's findings underscore the ongoing progress in cancer treatment technologies and the rising role of precision therapies like IMRT in improving patient outcomes while minimizing risks. As government support and demand for non-invasive options continue to grow, the IMRT market is well-positioned for steady expansion in the years ahead.

Emergen Research has segmented the global Intensity Modulated Radiotherapy (IMRT) market on the basis of radiation type, application, end-use, and region:

Radiation Type Outlook (Revenue, USD Billion; 2019-2032)
Electron radiation
Proton radiation
Photon radiation
Carbon-ion radiation

Application Outlook (Revenue, USD Billion; 2019-2032)
Breast cancer
Prostate cancer
Gastrointestinal (GI) cancer
Brain cancer
Lung cancer
Gynecological cancers
Others

End-use Outlook (Revenue, USD Billion; 2019-2032)
Hospitals
Cancer treatment centers
Radiation oncology clinics
Academic medical centers
Others

Regional Outlook (Revenue, USD Billion; 2019-2032)
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of Middle East & Africa
Make Payment [Buy your Exclusive copy] @ https://www.emergenresearch.com/select-license/2391

14671 110 Avenue, Surrey, British Columbia, V3R2A9
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.